The drive towards novel drug presentation and injectable-grade products is generating increased demand for aseptic pharmaceutical processing, including aseptic spray-drying (ASD). But what considerations need to be made for aseptic spray-drying programmes at laboratory stage to enable them to be efficiently scaled up from feasibility assessment to large-scale manufacture? Sam de Costa of Nova Laboratories shares his insights and considerations for a smooth transition.
https://international-pharma.com/wp-content/uploads/2014/07/Aseptic.pdf